These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17512352)

  • 1. The management of recurrent ovarian cancer.
    Bukowski RM; Ozols RF; Markman M
    Semin Oncol; 2007 Apr; 34(2 Suppl 2):S1-15. PubMed ID: 17512352
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian cancer: a focus on management of recurrent disease.
    Herzog TJ; Pothuri B
    Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decision-making of treatment and relative problems about recurrent and drug-resistant gynecologic neoplasms].
    Xie X; Cheng XD
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):801-3. PubMed ID: 21211274
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy for ovarian cancer--general review].
    Ochiai K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():517-21. PubMed ID: 15535299
    [No Abstract]   [Full Text] [Related]  

  • 5. New developments in the management of ovarian cancer.
    Hoskins WJ
    J Med Assoc Ga; 2003; 92(1):23-6, 33. PubMed ID: 12743902
    [No Abstract]   [Full Text] [Related]  

  • 6. Ovarian cancer.
    Bapsy PP
    J Indian Med Assoc; 2012 Dec; 110(12):894-7. PubMed ID: 23936953
    [No Abstract]   [Full Text] [Related]  

  • 7. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer: strategies for overcoming resistance to chemotherapy.
    Agarwal R; Kaye SB
    Nat Rev Cancer; 2003 Jul; 3(7):502-16. PubMed ID: 12835670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer ovary, present and future of management.
    Parvez T
    J Ayub Med Coll Abbottabad; 2003; 15(2):65-8. PubMed ID: 14552255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease.
    Michener CM; Belinson JL
    Oncology (Williston Park); 2005 Sep; 19(10):1277-85; discussion 1285, 1288, 1293. PubMed ID: 16285224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.
    Vergote I; Amant F
    Gynecol Oncol; 2006 Sep; 102(3):415-7. PubMed ID: 16979430
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ovarian cancer].
    Langmár Z; Csömör S; Németh M; Tomcsik Z; Joó JG
    Orv Hetil; 2011 Dec; 152(49):1977-84. PubMed ID: 22106167
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer.
    Fujiwara K
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():354-8. PubMed ID: 10895180
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic concept in ovarian cancer].
    Rath W; Meden H
    Med Klin (Munich); 1991 May; 86(5):263-8. PubMed ID: 1875867
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel therapies for recurrent ovarian cancer management.
    Bhoola SM; Alvarez RD
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):437-48. PubMed ID: 15161442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
    Tropé C; Kaern J; Vergote I
    Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ovarian carcinoma: various aspects of intraperitoneal chemotherapy].
    Los G; Beijnen JH; Dubbelman R; ten Bokkel Huinink WW; McVie JG
    Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1347-50. PubMed ID: 3412503
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving outcomes in ovarian cancer.
    Vaughan M; Sykes P; Johnson C; Fitzharris B;
    N Z Med J; 2006 Sep; 119(1242):U2171. PubMed ID: 16998572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Remote results of the standard ovary cancer treatment].
    Ushakov II; Mel'ko AI; Kira EF; Ermolinskiĭ II
    Voen Med Zh; 2005 Nov; 326(11):36-8. PubMed ID: 16404905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.